Total Payments
$1,726
2024 Payments
$526.05
Companies
10
Transactions
153
Medicare Patients
1,061
Medicare Billing
$124,903
Payment Breakdown by Category
Food & Beverage$1,726 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,726 | 153 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,153 | 138 | $0 (2024) |
| Allergan, Inc. | $187.79 | 5 | $0 (2020) |
| Ceribell, Inc. | $160.53 | 1 | $0 (2023) |
| Lilly USA, LLC | $46.50 | 2 | $0 (2024) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $43.78 | 2 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $38.56 | 1 | $0 (2022) |
| Averitas Pharma Inc. | $31.58 | 1 | $0 (2024) |
| Eisai Inc. | $25.32 | 1 | $0 (2024) |
| IMPEL PHARMACEUTICALS INC. | $24.91 | 1 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $14.11 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $526.05 | 42 | ABBVIE INC. ($402.84) |
| 2023 | $584.78 | 47 | AbbVie Inc. ($385.23) |
| 2022 | $299.80 | 32 | ABBVIE INC. ($237.27) |
| 2021 | $127.74 | 27 | AbbVie Inc. ($127.74) |
| 2020 | $187.79 | 5 | Allergan, Inc. ($187.79) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Neuroscience | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Neurology | ||||||
| 07/30/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 251 | 278 | $67,801 | $24,119 |
| 2022 | 8 | 224 | 247 | $79,883 | $24,920 |
| 2021 | 7 | 293 | 350 | $115,208 | $39,506 |
| 2020 | 7 | 293 | 346 | $116,969 | $36,358 |
Total Patients
1,061
Total Services
1,221
Medicare Billing
$124,903
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 117 | 140 | $25,459 | $10,532 | 41.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 31 | 31 | $12,171 | $4,498 | 37.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $15,230 | $3,390 | 22.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 29 | $7,463 | $2,940 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 21 | $3,819 | $1,639 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 29 | 31 | $3,660 | $1,120 | 30.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 50 | $29,288 | $7,838 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 33 | 38 | $9,779 | $3,757 | 38.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 24 | 24 | $9,422 | $3,652 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 48 | 52 | $9,456 | $3,067 | 32.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 11 | 20 | $8,003 | $2,112 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 35 | 38 | $4,486 | $2,042 | 45.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $4,685 | $1,260 | 26.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 14 | $4,764 | $1,192 | 25.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 81 | 87 | $50,960 | $14,653 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 102 | 141 | $25,641 | $10,700 | 41.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 38 | 38 | $14,919 | $5,940 | 39.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 23 | 23 | $5,919 | $2,897 | 48.9% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 11 | 20 | $8,003 | $2,074 | 25.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 16 | $6,814 | $1,851 | 27.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 24 | 25 | $2,951 | $1,389 | 47.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 79 | 84 | $49,203 | $14,215 | 28.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 59 | 59 | $23,163 | $7,831 | 33.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 84 | 112 | $20,367 | $7,311 | 35.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 27 | 28 | $7,206 | $2,675 | 37.1% |
About Hugh Cahill
Hugh Cahill is a Neurology healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2015. The National Provider Identifier (NPI) number assigned to this provider is 1982091666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hugh Cahill has received a total of $1,726 in payments from pharmaceutical and medical device companies, with $526.05 received in 2024. These payments were reported across 153 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,726).
As a Medicare-enrolled provider, Cahill has provided services to 1,061 Medicare beneficiaries, totaling 1,221 services with total Medicare billing of $124,903. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location White Plains, NY
- Active Since 04/21/2015
- Last Updated 08/28/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1982091666
Products in Payments
- UBRELVY (Drug) $685.46
- QULIPTA (Drug) $509.54
- Ceribell Rapid Response EEG (Device) $160.53
- BOTOX (Biological) $145.87
- RADICAVA (Drug) $43.78
- NURTEC ODT (Drug) $38.56
- QUTENZA (Drug) $31.58
- Leqembi (Drug) $25.32
- KISUNLA (Drug) $25.04
- Trudhesa (Drug) $24.91
- AMYVID (Drug) $21.46
- AJOVY (Biological) $14.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in White Plains
Dr. John Docherty, M.d, M.D
Neurology — Payments: $99,985
Neurology $99,985
Jeffrey Politsky, M.d, M.D
Neurology — Payments: $8,012
Neurology $8,012
Shahid Parvez, Md, MD
Neurology — Payments: $4,283
Neurology $4,283
Dr. Olgica Laban Grant, Md, MD
Neurology — Payments: $3,342
Neurology $3,342
Dr. Yves Lebrun, Md, MD
Neurology — Payments: $2,446
Neurology $2,446
Dr. Andrew Decker, Md, MD
Neurology — Payments: $2,391
Neurology $2,391